This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kaye, E. M. Articles by Breakefield, X. O. Search for Related Content PubMed PubMed Citation Articles by Kaye, E. M. Articles by Breakefield, X. O. Social Bookmarking                         What's this?

β-Galactosidase Gene Mutations in Patients With Slowly Progressive GM1 Gangliosidosis

Molecular Neurogenetics Unit, Massachusetts General Hospital East and the Department of Neurology, Harvard Medical School Boston, MA

Christo Shalish, BS

Molecular Neurogenetics Unit, Massachusetts General Hospital East and the Department of Neurology, Harvard Medical School Boston, MA

James Livermore, BS

Molecular Neurogenetics Unit, Massachusetts General Hospital East and the Department of Neurology, Harvard Medical School Boston, MA

Harold A. Taylor, MD

The Greenwood Genetics Center Greenwood, NC

Roger E. Stevenson, MD

The Greenwood Genetics Center Greenwood, NC

Xandra O. Breakefield, PhD

Molecular Neurogenetics Unit, Massachusetts General Hospital East and the Department of Neurology, Harvard Medical School Boston, MA

Three unrelated North American cases with slowly progressive forms of G_M1 gangliosidosis were found to have two unique point mutations and a 9 bp insertion in the coding region of the gene encoding β-galactosidase. Case 1 was noted to have a 9 bp insertion {CAGAATTTT} on one allele between nucleotides 730 and 731 with no other mutations identified in the other allele. In case 2, two point mutations were found: a unique GA transition at nucleotide 602 causing an ArgHis substitution in codon 201 (mutation R201H); and a previously identified GT transition at nucleotide 1527 causing a TrpCys substitution in codon 509 (mutation W509C), which has been noted in adult and chronic forms of G_M1 gangliosidosis. Case 3 had a unique point mutation (AG transition at nucleotide 797) resulting in a AsnSer amino acid substitution in codon 266 (mutation N266S), with no other mutations found in the same or the other allele. Single-strand conformation polymorphism performed on over 100 controls did not demonstrate the presence of the point mutations R201H or N266S. Also, the mutant proteins coded by the two point mutations did not show enzymatic activity in the Cos-1 cell expression system confirming that these mutations are associated with low enzyme activity. ( J Child Neurol 1997;12:242—247).

Journal of Child Neurology, Vol. 12, No. 4, 242-247 (1997)
DOI: 10.1177/088307389701200404


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Wen, M. M. Vecchi, S. Gu, L. Su, J. Dolnikova, Y.-M. Huang, S. F. Foley, E. Garber, N. Pederson, and W. Meier Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells J. Biol. Chem., November 20, 2009; 284(47): 32686 - 32694. [Abstract] [Full Text] [PDF]

				R. Santamaria, A. Chabas, J. W. Callahan, D. Grinberg, and L. Vilageliu Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients J. Lipid Res., October 1, 2007; 48(10): 2275 - 2282. [Abstract] [Full Text] [PDF]

				A. Caciotti, M. A. Donati, T. Bardelli, A. d'Azzo, G. Massai, L. Luciani, E. Zammarchi, and A. Morrone Primary and Secondary Elastin-Binding Protein Defect Leads to Impaired Elastogenesis in Fibroblasts from GM1-Gangliosidosis Patients Am. J. Pathol., December 1, 2005; 167(6): 1689 - 1698. [Abstract] [Full Text] [PDF]